Author Correction: Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

por Zhang, Jie, Lin, Xiao-Tong, Yu, Hong-Qiang, Fang, Lei, Wu, Di, Luo, Yuan-Deng, Zhang, Yu-Jun, Xie, Chuan-Ming
Publicado 2023

Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice

por Zhang, Jie, Lin, Xiao-Tong, Yu, Hong-Qiang, Fang, Lei, Wu, Di, Luo, Yuan-Deng, Zhang, Yu-Jun, Xie, Chuan-Ming
Publicado 2023

Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling

por Luo, Yuan-Deng, Liu, Xiao-Yu, Fang, Lei, Yu, Hong-Qiang, Zhang, Yu-Jun, Chen, Min, Zhang, Lei-Da, Xie, Chuan-Ming
Publicado 2022

Reduced IκBα promotes hepatocellular carcinoma cell proliferation and migration via regulation of NF-κB/Erbin axis

por Tan, Ye, Lin, Xiao-Tong, Luo, Yuan-Deng, Zhang, Jie, Fang, Lei, Zhu, Yan-Yin, Yu, Hong-Qiang, Shuai, Ling, Jiang, Yan, Zhang, Lei-Da, Bie, Ping, Xie, Chuan-Ming
Publicado 2020

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma

por Luo, Yuan‐Deng, Yu, Hong‐Qiang, Liu, Xiao‐Yu, Huang, Deng, Dai, Hai‐Su, Fang, Lei, Zhang, Yu‐Jun, Lai, Jie‐Juan, Jiang, Yan, Shuai, Ling, Zhang, Lei‐Da, Chen, Geng, Bie, Ping, Xie, Chuan‐Ming
Publicado 2020